Clinical Trial Update: Low Nicotine Content Cigarettes in Vulnerable Populations: Opioid Use Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial sponsored by the University of Vermont evaluating low nicotine content cigarettes in individuals with tobacco use disorder and opioid u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder
• Tobacco Use Disorder

Drugs mentioned

• Low nicotine content cigarettes

Snippet

Sponsor: University of Vermont | Conditions: Tobacco Use Disorder | Phase 2 | Status: COMPLETED | Results posted: 2025-03-30